Clinical Research Directory

Inclusion Criteria: * Age ≥18 years, with no restriction on sex. * Acute mesenteric ischemia (AMI) caused by superior mesenteric artery (SMA) thrombosis or thromboembolism. * The participant or legally authorized representative can provide written informed consent, and the participant is willing and able to comply with the follow-up requirements. Exclusion Criteria: * Presence of unfavorable vascular anatomical factors, including severe arterial tortuosity, concomitant aortic disease, superior mesenteric artery aneurysm, or other anatomical conditions considered unsuitable for endovascular intervention. * Acute major myocardial infarction, extensive cerebral infarction, or severe heart failure within 1 month before enrollment. * Patients unable to receive regular anticoagulation, thrombolytic therapy, or antiplatelet therapy due to gastrointestinal bleeding, severe allergic reactions, coagulation disorders, severe hepatic or renal dysfunction, or other contraindications. * Patients unable to undergo endovascular procedures due to severe contrast media allergy, severe renal insufficiency, or other contraindications. * History of previous superior mesenteric artery (SMA) thromboembolism or thrombosis. * Patients with confirmed intestinal necrosis before the procedure who underwent direct exploratory laparotomy without receiving endovascular intervention. * Pregnant or breastfeeding women. * Patients currently participating in other interventional device or drug clinical trials. * Any other conditions deemed inappropriate for enrollment by the investigator.